Table 2.
Summary of linear mixed models examining nighttime sleep as a predictor of morning pain intensity (N = 67)
| Number of observations | Complete model | Trimmed model | ||
|---|---|---|---|---|
|
|
|
|||
| Predictor variables | β (SE) | Predictor variables | β (SE) | |
| 412 | Sleep duration | −.003 (.001)** | Sleep duration | −.003 (.001)** |
| Sex | −.30 (.44) | |||
| Age | .11 (.11) | |||
| Medication category | .38 (.22) | |||
| Nap (yes/no) | −.30 (.30) | |||
| Fracture (yes/no) | .46 (.53) | |||
| 452 | Sleep quality | −.12 (.05)** | Sleep quality | −.13 (.04)** |
| Sex | −.35 (.44) | |||
| Age | .15 (.11) | |||
| Medication category | .35 (.22) | |||
| Nap (yes/no) | −.15 (.38) | |||
| Fracture (yes/no) | .17 (.52) | |||
| 412 | Sleep efficiency | −.02 (.01) | Sleep efficiency | −.01 (.01) |
| Sex | −.33 (.44) | |||
| Age | .13 (.11) | |||
| Medication category | .39 (.22) | |||
| Nap (yes/no) | −.25 (.31) | |||
| Fracture (yes/no) | .38 (.53) | |||
| 412 | WASO | −.002 (.002) | WASO | −.002 (.002) |
| Sex | −.31 (.45) | |||
| Age | .14 (.12) | |||
| Medication category | .38 (.23) | |||
| Nap (yes/no) | −.28 (.31) | |||
| Fracture (yes/no) | .36 (.54) | |||
**
p <.01